Cell Reports Medicine

Cell Reports Medicine is a monthly gold open-access journal published by Cell Press since 2020, covering translational and clinical biomedical research across medicine, with a 2025 Journal Impact Factor of 14.0 and the sister journal of Cell Reports（Cell Reports Medicine）是由（Cell Press）自 2020 年起出版的月刊金色开放获取期刊，刊载面向医学各领域的转化与临床生物医学研究，2025 年影响因子为 14.0，是（Cell Reports）的姊妹刊。

Scope

• It publishes cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine刊载能够指导并影响人类健康与医学的转化与临床生物医学前沿研究。
• Its content reaches a broad range of scientists and clinicians across the whole spectrum of medical disciplines其内容面向医学各学科领域的广大科学家与临床医生。
• It publishes original research ranging from concepts in human biology, health and disease to all phases of clinical work刊载原创研究，从人类生物学、健康与疾病的基础概念，到临床工作的各个阶段。^[1][2]
• It encourages submissions with innovative ideas that open up new directions in clinical research and practice欢迎提出创新思路、开辟临床研究与实践中新方向的投稿。
• It welcomes studies that enrich understanding of current standards of care in diagnosis, treatment and prognosis亦欢迎能增进对诊断、治疗与预后现有诊疗标准认识的论文。
• Coverage includes translational studies, clinical trials in all areas of medicine, genomics, biomarker discovery and technology for diagnostics, treatment and healthcare覆盖转化研究、医学各领域的临床试验、基因组学、生物标志物发现，以及服务于诊断、治疗与医疗的技术。^[3]

History

• It was launched by Cell Press in July 2020 as a broad-scope open-access companion to Cell Reports该刊于 2020 年 7 月由（Cell Press）创办，是（Cell Reports）的广域开放获取姊妹刊。
• It belongs to the Cell Reports portfolio of gold open-access journals spanning life, medical and physical sciences该刊属于（Cell Reports）系列金色开放获取期刊组合，覆盖生命科学、医学与物理科学。
• It is an online-only journal identified by the electronic ISSN 2666-3791该刊为纯在线期刊，其电子国际标准刊号（eISSN）为 2666-3791。
• It is indexed in Science Citation Index Expanded, Scopus, PubMed and the Directory of Open Access Journals该刊被（Science Citation Index Expanded）、（Scopus）、（PubMed）与（Directory of Open Access Journals）收录。
• It rapidly became one of the fastest-growing Cell Press journals, publishing about 417 research articles a year with a gold open-access share near 99 percent该刊迅速成长为（Cell Press）增长最快的期刊之一，每年发表约 417 篇研究论文，金色开放获取比例接近 99%。
• Its Journal Impact Factor was 16.988 in 2022, 10.6 in 2024 and 14.0 in 2025其影响因子 2022 年为 16.988，2024 年为 10.6，2025 年为 14.0。

Editors

• Its Editor-in-Chief is Sara Hamilton, a biochemist who holds a PhD and is based in Cambridge in the United States其主编为（Sara Hamilton），拥有生物化学博士学位，常驻美国（Cambridge）。
• She spent five years as a scientific editor at Cell Reports before taking charge of Cell Reports Medicine她此前在（Cell Reports）任科学编辑五年，其后执掌（Cell Reports Medicine）。
• Its in-house scientific editors work closely with authors, reviewers and an editorial board to ensure fair and robust peer review其内部科学编辑与作者、审稿人及编辑委员会紧密协作，确保公正而稳健的同行评审。
• Its Associate Scientific Editors include Elisa Panada in London and Charlotte Owen-Woods in Oxford其副科学编辑包括（Elisa Panada）（伦敦）与（Charlotte Owen-Woods）（牛津）。
• Kristan van der Vos in Amsterdam and Sha Yu in Shanghai also serve as Associate Scientific Editors（Kristan van der Vos）（阿姆斯特丹）与（Sha Yu）（上海）亦担任副科学编辑。
• The editorial team is international, spanning the United States, the United Kingdom, the Netherlands and China编辑团队来自多个国家，横跨美国、英国、荷兰与中国。